Stocks
GoodRx Holdings (GDRX) EBITDA margin US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -46.7% | 6.44% | 8.50% | 8.50% | 21.7% | 14.3% | ||
| Changes by years, y/y, % | -86pp | +53pp | +2pp | 0pp | +13pp | -9.1% | |||
GoodRx Holdings. EBITDA margin, %
GoodRx Holdings. EBITDA margin, changes, pp
GoodRx Holdings (GDRX) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA margin, % | ? | 17.2% | 22.3% | 0.64% | 14.9% | 18.4% | 14.3% | |
| Changes by years, y/y, % | +2pp | +17pp | +0pp | +3pp | +1pp | |||
| Changes by quarters, q/q, % | +5pp | +5pp | -22pp | +14pp | +4pp | |||
